This report includes forward-looking statements based on the Company's current
assumptions, expectations and projections about future events. When used in this
report, the words "believes," "anticipates," "may," "expect," "intend,"
"estimate," "project" and similar expressions are intended to identify
forward-looking statements, although not all forward-looking statements contain
such words. In this report, the Company discloses important factors that could
cause actual results to differ materially from management's expectations. For
more information on these and other factors, see "Forward-Looking Information"
herein.

The following Management's Discussion and Analysis of Financial Condition and
Results of Operations should be read in conjunction with "Item 1A. Risk
Factors," and the consolidated financial statements and related notes included
elsewhere in this Annual Report on Form 10-K.

Business Overview



AMETEK's operations are affected by global, regional and industry-specific
economic factors. However, the Company's strategic geographic and industry
diversification, and its mix of products and services, have helped to mitigate
the potential adverse impact of any unfavorable developments in any one industry
or the economy of any single country on its consolidated operating results. In
2022, the Company posted record sales, operating income, operating margins, net
income, diluted earnings per share, backlog, and orders. The Company also
benefited from its strategic initiatives under AMETEK's four key strategies:
Operational Excellence, Strategic Acquisitions, Global & Market Expansion and
New Products.

Highlights in 2022 were:

•Net sales for 2022 were a record $6,150.5 million, an increase of $604.0 million or 10.9%, compared with net sales of $5,546.5 million in 2021. The increase in net sales for 2022 was due to an 11% organic sales increase, a 2% increase from acquisitions, partially offset by an unfavorable 2% effect of foreign currency translation.

•Net income for 2022 was a record $1,159.5 million, an increase of $169.4 million or 17.1%, compared with $990.1 million in 2021.

•Diluted earnings per share for 2022 were a record $5.01, an increase of $0.76 or 17.8%, compared with $4.25 per diluted share in 2021.



•Orders for 2022 were a record $6,639.1 million, an increase of $164.7 million
or 2.5%, compared with $6,474.4 million in 2021. The increase in orders was due
to a 9% organic order increase, partially offset by a 3% unfavorable effect of
foreign currency translation, as well as a 3% decrease from the year-over-year
impact of acquisitions. As a result, the Company's backlog of unfilled orders at
December 31, 2022 was a record $3,218.6 million.

•During 2022, the Company spent $429.7 million in cash, net of cash acquired, to purchase two businesses:

•In September 2022, AMETEK acquired Navitar, Inc. ("Navitar"), a designer and manufacturer of customized, fully integrated optical imaging systems, components, and software.



•In October 2022, AMETEK acquired RTDS Technologies Inc. ("RTDS"), a leading
provider of real-time power simulation systems used by utilities, and research
and education institutions in the development and testing of the electric power
grid and renewable energy applications.

•Cash flow provided by operating activities for 2022 was $1,149.4 million. Free
cash flow (cash flow provided by operating activities less capital expenditures)
was $1,010.4 million in 2022.
                                       23

--------------------------------------------------------------------------------

Table of Contents

•EBITDA (earnings before interest, income taxes, depreciation, and amortization) was a record $1,829.7 million in 2022, compared with $1,594.3 million in 2021.



•The Company continued its emphasis on investment in research, development and
engineering, spending $322.1 million in 2022. Sales from products introduced in
the past three years were $1,674.2 million.

Recent Events and Market Conditions



Recent events and market conditions impacting our business include the
inflationary cost environment, rising interest rates, supply chain constraints,
the COVID-19 pandemic, and the ongoing conflict in Ukraine. As a result of these
events and conditions, we anticipate the challenging global economic environment
to continue into 2023.

Beginning in 2021, we experienced heightened levels of inflation in material and
transportation costs. We have taken steps to mitigate the impacts of material
and transportation cost inflation by implementing pricing actions. We
experienced additional pressure in our supply chain due to component shortages
and strained transportation capacity, as well as the impact of continued
elevated customer demand. In response to these supply chain pressures, we have
taken actions to build inventory and seek alternative sources of supply to
support sales and backlog growth. The inflationary environment has also resulted
in central banks raising short-term interest rates. We expect inflation to
continue into 2023 and will continue to take actions to mitigate this
inflationary pressure.

There still remains uncertainty concerning the COVID-19 pandemic, its effect on
labor, government mandated lockdowns and other restrictive measures, and the
pandemic's ultimate duration. Lockdowns in China during 2022 limited our ability
to access customer sites, operate certain facilities, and placed additional
constraints on our supply chain. Depending on the course of the pandemic,
additional lockdowns in China or elsewhere could impact our operations and
results of operations.

The invasion of Ukraine by Russia and the sanctions imposed in response to this
conflict have increased global economic and political uncertainty. While we do
not have operations in Russia or Ukraine and do not have significant exposure to
customers and vendors in those countries, a significant expansion of the
conflict's current scope could further complicate the economic environment.

While the ultimate impact of these events remains uncertain, we will continue to
evaluate the extent to which these factors will impact our business, financial
condition, and results of operations.


                                       24

--------------------------------------------------------------------------------

Table of Contents

Results of Operations



The following table sets forth net sales and income by reportable segment and on
a consolidated basis:

                                                                          Year Ended December 31,
                                                               2022                 2021                 2020
                                                                               (In thousands)
Net sales:
Electronic Instruments                                    $ 4,229,353          $ 3,763,758          $ 2,989,928
Electromechanical                                           1,921,177            1,782,756            1,550,101
Consolidated net sales                                    $ 6,150,530          $ 5,546,514          $ 4,540,029
Operating income and income before income taxes:
Segment operating income:
Electronic Instruments                                    $ 1,089,729          $   958,183          $   770,620
Electromechanical                                             503,593              437,378              324,962
Total segment operating income                              1,593,322            1,395,561            1,095,582
Corporate administrative expenses                             (92,630)             (86,891)             (67,698)
Consolidated operating income                               1,500,692            1,308,670            1,027,884
Interest expense                                              (83,186)             (80,381)             (86,062)
Other (expense) income, net                                    11,186               (5,119)             140,487
Consolidated income before income taxes                   $ 1,428,692

$ 1,223,170 $ 1,082,309

______________________



The following "Results of Operations of the year ended December 31, 2022
compared with the year ended December 31, 2021" section presents an analysis of
the Company's consolidated operating results displayed in the Consolidated
Statement of Income. A discussion regarding our financial condition and results
of operations for the year ended December 31, 2021 compared to the year ended
December 31, 2020 can be found under Item 7 in our Annual Report on Form 10-K
for the fiscal year ended December 31, 2021, filed with the Securities and
Exchange Commission on February 22, 2022.

Results of Operations for the year ended December 31, 2022 compared with the year ended December 31, 2021



Net sales for 2022 were a record $6,150.5 million, an increase of $604.0 million
or 10.9%, compared with net sales of $5,546.5 million in 2021. The increase in
net sales for 2022 was due to an 11% organic sales increase, a 2% increase from
acquisitions, partially offset by an unfavorable 2% effect of foreign currency
translation. EIG net sales were $4,229.4 million in 2022, an increase of 12.4%,
compared with $3,763.8 million in 2021. EMG net sales were $1,921.2 million in
2022, an increase of 7.8%, compared with $1,782.8 million in 2021.

Total international sales for 2022 were $2,996.3 million or 48.7% of net sales,
an increase of $250.7 million or 9.1%, compared with international sales of
$2,745.6 million or 49.5% of net sales in 2021. The increase in international
sales was primarily driven by strong demand in all regions as well as
contributions from recent acquisitions. Export shipments from the United States,
which are included in total international sales, were $1,688.7 million in 2022,
an increase of $213.1 million or 14.4%, compared with $1,475.6 million in 2021.

Orders for 2022 were a record $6,639.1 million, an increase of $164.7 million or
2.5% compared with $6,474.4 million in 2021. The increase in orders was due to a
9% organic order increase, partially offset by a 3% unfavorable effect of
foreign currency translation, as well as a 3% decrease from the year-over-year
impact of acquisitions. The Company's backlog of unfilled orders at December 31,
2022 was a record $3,218.6 million, an increase of $488.5 million or 17.9%,
compared with $2,730.1 million at December 31, 2021.
                                       25

--------------------------------------------------------------------------------

Table of Contents



Segment operating income for 2022 was $1,593.3 million, an increase of $197.7
million or 14.2%, compared with segment operating income of $1,395.6 million in
2021. Segment operating income was positively impacted in 2022 by the increased
sales discussed above. Segment operating income, as a percentage of net sales,
increased to 25.9% in 2022, compared with 25.2% in 2021. Segment operating
margins for 2022 were negatively impacted by the dilutive impact of the 2021
acquisitions. Excluding the dilutive impact of recent acquisitions, segment
operating margins for the core businesses increased 120 basis points compared to
2021, due to the Company's Operational Excellence initiatives.

Cost of sales for 2022 was $4,005.3 million or 65.1% of net sales, an increase
of $371.4 million or 10.2%, compared with $3,633.9 million or 65.5% of net sales
for 2021. The cost of sales increase was primarily due to the net sales increase
discussed above.

Selling, general and administrative expenses for 2022 were $644.6 million or
10.5% of net sales, an increase of $40.7 million or 6.7%, compared with $603.9
million or 10.9% of net sales in 2021. Selling, general and administrative
expenses increased primarily due to the increase in net sales discussed above.

Consolidated operating income was $1,500.7 million or a record 24.4% of net sales for 2022, an increase of $192.0 million or 14.7%, compared with $1,308.7 million or 23.6% of net sales in 2021.

Other income, net was $11.2 million for 2022, compared with $5.1 million of other expense in 2021, a change of $16.3 million. During 2022, the Company recorded higher pension income of $9.9 million and lower acquisition-related due diligence expense compared to 2021.



The effective tax rate for 2022 was 18.8%, compared with 19.1% in 2021. See Note
9 to the Consolidated Financial Statements included in Part II, Item 8 of this
Annual Report on Form 10-K for further details.

Net income for 2022 was a record $1,159.5 million, an increase of $169.4 million or 17.1%, compared with $990.1 million in 2021.

Diluted earnings per share for 2022 were a record $5.01, an increase of $0.76 or 17.8%, compared with $4.25 per diluted share in 2021.

Segment Results



EIG's net sales totaled a record $4,229.4 million for 2022, an increase of
$465.6 million or 12.4%, compared with $3,763.8 million in 2021. The net sales
increase was due to an 11% organic sales increase, a 4% increase from
acquisitions, partially offset by an unfavorable 3% effect of foreign currency
translation.

EIG's operating income was a record $1,089.7 million for 2022, an increase of
$131.5 million or 13.7%, compared with $958.2 million in 2021. EIG's operating
margins were 25.8% of net sales for 2022, compared with 25.5% of net sales in
2021. EIG's operating margins in 2022 were negatively impacted by the dilutive
impact of the 2021 acquisitions. Excluding the dilutive impact of the 2021
acquisitions, EIG operating margins increased 100 basis points compared to 2021,
due to the increase in net sales discussed above, as well as continued benefits
from the Company's Operational Excellence initiatives.

EMG's net sales totaled a record $1,921.2 million for 2022, an increase of $138.4 million or 7.8%, compared with $1,782.8 million in 2021. The net sales increase was due to an 11% organic sales increase, partially offset by an unfavorable 3% effect of foreign currency translations.



EMG's operating income was a record $503.6 million for 2022, an increase of
$66.2 million or 15.1%, compared with $437.4 million in 2021. EMG's operating
income included a $7.1 million gain on the sale of a facility during 2022. EMG's
operating margins were a record 26.2% of net sales for 2022, compared with 24.5%
of net sales in 2021. Excluding the gain on the sale of a facility, EMG
operating margins increased 130 basis points compared to
                                       26

--------------------------------------------------------------------------------

Table of Contents

2021, due to the increase in net sales discussed above, as well as continued benefits from the Company's Operational Excellence initiatives.

Liquidity and Capital Resources



Cash provided by operating activities totaled $1,149.4 million in 2022, a
decrease of $11.1 million or 1.0%, compared with $1,160.5 million in 2021. The
decrease in cash provided by operating activities for 2022 was due to higher
working capital levels, primarily driven by higher investments in inventory to
support sales and backlog growth, and to mitigate inventory supply chain
constraints, partially offset by higher net income.

Free cash flow (cash flow provided by operating activities less capital
expenditures) was $1,010.4 million in 2022, compared with $1,049.8 million in
2021. EBITDA (earnings before interest, income taxes, depreciation and
amortization) was a record $1,829.7 million in 2022, compared with $1,594.3
million in 2021. Free cash flow and EBITDA are presented because the Company is
aware that they are measures used by third parties in evaluating the Company.
(See "Non-GAAP Financial Measures" for a reconciliation of U.S. GAAP measures to
comparable non-GAAP measures).

Cash used by investing activities totaled $552.8 million in 2022, compared with
cash used by investing activities of $2,055.8 million in 2021. In 2022, the
Company paid $429.7 million, net of cash acquired, to purchase Navitar, Inc. and
RTDS Technologies Inc., compared to $1,959.2 million, net of cash acquired, to
purchase Abaco Systems, Magnetrol International, NSI-MI Technologies, Crank
Software, EGS Automation, and Alphasense in 2021. Additions to property, plant
and equipment totaled $139.0 million in 2022, compared with $110.7 million in
2021.

Cash used by financing activities totaled $575.7 million in 2022, compared with
$39.3 million of cash provided by financing activities in 2021. At December 31,
2022, total debt, net was $2,385.0 million, compared with $2,544.2 million at
December 31, 2021. In 2022, total borrowings decreased by $73.7 million,
compared with an increase of $183.9 million in 2021. At December 31, 2022, the
Company had available borrowing capacity of $2,745.2 million under its revolving
credit facility and term loan, including the $700 million accordion feature.

On May 12, 2022, the Company along with certain of its foreign subsidiaries
amended and restated its Credit Agreement dated as of September 22, 2011, as
amended and restated as of March 10, 2016 and as further amended and restated as
of October 30, 2018, with the lenders, JPMorgan Chase Bank, N.A., as
Administrative Agent and Bank of America, N.A., PNC Bank, National Association,
Trust Bank and Wells Fargo Bank, National Association, as Co-Syndication Agents.
The credit agreement amends and restates the Company's existing revolving credit
facility to increase the size from $1.5 billion to $2.3 billion and terminates
the $800 million term loan. The credit agreement places certain restrictions on
allowable additional indebtedness. In November 2021, the Company further amended
the Credit Agreement to address the cessation of LIBOR on certain currencies. At
December 31, 2022, the Company had $219.0 million outstanding on the revolver
with a maturity date of May 2027.

In the fourth quarter of 2021, a 55 million Swiss franc ($59.7 million) 2.44%
senior note matured and was paid. The debt-to-capital ratio was 24.2% at
December 31, 2022, compared with 27.0% at December 31, 2021. The net
debt-to-capital ratio (total debt, net less cash and cash equivalents divided by
the sum of net debt and stockholders' equity) was 21.4% at December 31, 2022,
compared with 24.2% at December 31, 2021. The net debt-to-capital ratio is
presented because the Company is aware that this measure is used by third
parties in evaluating the Company. (See "Non-GAAP Financial Measures" for a
reconciliation of U.S. GAAP measures to comparable non-GAAP measures).

In 2022, the Company repurchased approximately 2.7 million shares of its common
stock for $332.8 million, compared with $14.7 million used for repurchases of
approximately 113,000 shares in 2021. Effective May 5, 2022, the Company's Board
of Directors approved a $1 billion share repurchase authorization. This
authorization replaces an earlier $500 million share repurchase authorization
approved by the Board in February 2019. At December 31, 2022, $823.9 million was
available under the Company's Board of Directors authorization for future share
repurchases.
                                       27

--------------------------------------------------------------------------------

Table of Contents



Additional financing activities for 2022 included cash dividends paid of $202.2
million, compared with $184.6 million in 2021. On February 9, 2022, the
Company's Board of Directors approved a 10% increase in the quarterly cash
dividend on the Company's common stock to $0.22 per common share from $0.20 per
common share. Proceeds from the exercise of employee stock options were $49.9
million in 2022, compared with $60.3 million in 2021.

As a result of all of the Company's cash flow activities in 2022, cash and cash
equivalents at December 31, 2022 totaled $345.4 million, compared with $346.8
million at December 31, 2021. At December 31, 2022, the Company had $334.1
million in cash outside the United States, compared with $344.0 million at
December 31, 2021. The Company utilizes this cash to fund its international
operations, as well as to acquire international businesses. The Company is in
compliance with all covenants, including financial covenants, for all of its
debt agreements. The Company believes it has sufficient cash-generating
capabilities from domestic and unrestricted foreign sources, available credit
facilities and access to long-term capital funds to enable it to meet its
operating needs and contractual obligations for the foreseeable future.

Subsequent Event

Effective February 9, 2023, the Company's Board of Directors approved a 14% increase in the quarterly cash dividend on the Company's common stock to $0.25 per common share from $0.22 per common share.

Contractual Obligations and Other Commitments

Material contractual obligations arising in the normal course of business primarily consist of purchase obligations, long-term debt and related interest payments, and leases. See Note 10 to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for more information on the nature and timing of debt obligations.



Leases expire over a range of years from 2023 to 2032. Most of the leases
contain renewal or purchase options, subject to various terms and conditions.
See Note 14 to the Consolidated Financial Statements included in Part II, Item 8
of this Annual Report on Form 10-K for more information on the nature and timing
of lease obligations.

Purchase obligations primarily consist of contractual commitments to purchase
certain inventories at fixed prices. At December 31, 2022, the Company had
$1,003.9 million of purchase obligations due within one year and $115.8 million
of purchase obligations due in more than one year.

The Company has standby letters of credit and surety bonds of $64.9 million
related to performance and payment guarantees at December 31, 2022. Based on
experience with these arrangements, the Company believes that any obligations
that may arise will not be material to its financial position.


                                       28

--------------------------------------------------------------------------------

Table of Contents

Non-GAAP Financial Measures



EBITDA represents earnings before interest, income taxes, depreciation and
amortization. EBITDA is presented because the Company is aware that it is used
by rating agencies, securities analysts, investors and other parties in
evaluating the Company. It should not be considered, however, as an alternative
to operating income as an indicator of the Company's operating performance or as
an alternative to cash flows as a measure of the Company's overall liquidity as
presented in the Company's consolidated financial statements. Furthermore,
EBITDA measures shown for the Company may not be comparable to similarly titled
measures used by other companies. The following table presents the
reconciliation of net income reported in accordance with U.S. generally accepted
accounting principles ("GAAP") to EBITDA:

                             Year Ended December 31,
                       2022           2021           2020
                                  (In millions)
Net income          $ 1,159.5      $   990.1      $   872.4
Add (deduct):
Interest expense         83.2           80.4           86.1
Interest income          (1.7)          (1.4)          (2.1)
Income taxes            269.2          233.1          209.9
Depreciation            113.7          108.5          101.3
Amortization            205.8          183.6          154.0
Total adjustments       670.2          604.2          549.2
EBITDA              $ 1,829.7      $ 1,594.3      $ 1,421.6


Free cash flow represents cash flow from operating activities less capital
expenditures. Free cash flow is presented because the Company is aware that it
is used by rating agencies, securities analysts, investors and other parties in
evaluating the Company. The following table presents the reconciliation of cash
flow from operating activities reported in accordance with U.S. GAAP to free
cash flow:

                                                   Year Ended December 31,
                                             2022           2021           2020
                                                        (In millions)
Cash provided by operating activities     $ 1,149.4      $ 1,160.5      $ 1,281.0
Deduct: Capital expenditures                 (139.0)        (110.7)         (74.2)
Free cash flow                            $ 1,010.4      $ 1,049.8      $ 1,206.8


Net debt represents total debt, net minus cash and cash equivalents. Net debt is
presented because the Company is aware that it is used by rating agencies,
securities analysts, investors and other parties in evaluating the Company. The
following table presents the reconciliation of total debt, net reported in
accordance with U.S. GAAP to net debt:

                                                              December 31,
                                                          2022            2021
                                                             (In millions)
Total debt, net                                       $ 2,385.0       $ 2,544.2
Less: Cash and cash equivalents                          (345.4)         (346.8)
Net debt                                                2,039.6         2,197.4
Stockholders' equity                                    7,476.5         6,871.9

Capitalization (net debt plus stockholders' equity) $ 9,516.1 $ 9,069.3 Net debt as a percentage of capitalization

                 21.4  %         24.2  %



                                       29

--------------------------------------------------------------------------------


  Table of Contents

Internal Reinvestment

Capital Expenditures

Capital expenditures were $139.0 million or 2.3% of net sales in 2022, compared
with $110.7 million or 2.0% of net sales in 2021. In 2022, approximately 64% of
capital expenditures were for improvements to existing equipment or additional
equipment to increase productivity and expand capacity. Capital expenditures in
2023 are expected to be approximately 2% of net sales, with a continued emphasis
on spending to improve productivity.

Research, Development and Engineering



The Company is committed to, and has consistently invested in, research,
development and engineering activities to design and develop new and improved
products and solutions. Research, development and engineering costs before
customer reimbursement were $322.1 million in 2022, $299.6 million in 2021 and
$246.2 million in 2020. These amounts included research and development expenses
of $198.8 million, $194.2 million and $158.9 million in 2022, 2021, and 2020,
respectively. All such expenditures were directed toward the development of new
products and solutions and the improvement of existing products and solutions.

Environmental Matters



Information with respect to environmental matters is set forth in Note 13 to the
Consolidated Financial Statements included in Part II, Item 8 of this Annual
Report on Form 10-K.


Critical Accounting Policies and Estimates



Critical accounting policies are those policies that can have a significant
impact on the presentation of the Company's financial condition and results of
operations and that require the use of complex and subjective estimates based on
the Company's historical experience and management's judgment. Because of the
uncertainty inherent in such estimates, actual results may differ materially
from the estimates used. Below are the policies used in preparing the Company's
financial statements that management believes are the most dependent upon the
application of estimates and assumptions. A complete list of the Company's
significant accounting policies is in Note 1 to the Consolidated Financial
Statements included in Part II, Item 8 of this Annual Report on Form 10-K.

•Business Combinations. The Company allocates the purchase price of an acquired
company, including when applicable, the acquisition date fair value of
contingent consideration between tangible and intangible assets acquired and
liabilities assumed from the acquired business based on their estimated fair
values, with the residual of the purchase price recorded as goodwill. Third
party appraisal firms and other consultants are engaged to assist management in
determining the fair values of certain assets acquired and liabilities assumed.
Estimating fair values requires significant judgments, estimates and
assumptions, including but not limited to: discount rates, future cash flows and
the economic lives of trade names, technology, and customer relationships. These
estimates are based on historical experience and information obtained from the
management of the acquired companies and are inherently uncertain.

•Goodwill and Other Intangible Assets. Goodwill and other intangible assets with
indefinite lives, primarily trademarks and trade names, are not amortized;
rather, they are tested for impairment at least annually. The Company performs
either a qualitative or quantitative analysis to determine if it is more likely
than not that the fair values of its reporting units are less than the
respective carrying values of those reporting units.

When testing goodwill for impairment, the Company has the option to first assess
qualitative factors to determine whether the existence of events or
circumstances leads to a determination that it is more likely than not that the
estimated fair value of a reporting unit is less than its carrying amount. If
the Company performs a qualitative assessment and determines that an impairment
is more likely than not, then performance of a quantitative impairment test is
required. In conducting a qualitative assessment, the
                                       30

--------------------------------------------------------------------------------

Table of Contents



Company analyzes actual and forecasted net sales and selling profit for each
reporting unit, as well as historical performance and the results of prior
quantitative tests performed. Additionally, the Company assesses critical areas
that may impact its business, including macroeconomic conditions, industry and
market conditions, cost factors, or any relevant events and factors that may
impact projected financial results.

If performed, the quantitative goodwill impairment test uses a discounted cash
flow analysis to determine the fair value of each reporting unit, which
considers cash flows discounted at an appropriate discount rate. The annual
goodwill impairment test requires the Company to make a number of assumptions
and estimates concerning future levels of revenue growth, operating margins,
depreciation, amortization and working capital requirements, which are based on
the Company's long-range plan and are considered level 3 inputs. The discount
rate is an estimate of the overall after-tax rate of return required by a market
participant whose weighted average cost of capital includes both equity and
debt, including a risk premium. While the Company uses the best available
information to prepare its cash flow and discount rate assumptions, actual
future cash flows or market conditions could differ significantly resulting in
future impairment charges related to recorded goodwill balances.

The impairment test for indefinite-lived intangibles other than goodwill
(primarily trademarks and trade names) consists of a comparison of the estimated
fair value of the indefinite-lived intangible asset to the carrying value of the
asset as of the impairment testing date. The Company can elect to perform a
qualitative analysis to determine if it is more likely than not that the fair
values of its indefinite-lived intangible assets are less than the respective
carrying values of those assets. The Company elected to perform its annual
goodwill impairment test using the quantitative analysis method. The Company may
elect to perform the quantitative analysis in future periods. The Company
estimates the fair value of its indefinite-lived intangibles using the relief
from royalty method using level 3 inputs, which is a widely used valuation
technique for such assets. The fair value derived from the relief from royalty
method is determined by applying a royalty rate to a projection of net revenues
discounted using an appropriate discount rate. Each royalty rate is determined
based on the profitability of the trade name to which it relates and observed
market royalty rates. Certain impairment models have discount rates calculated
based on a debt/equity cost of capital. While the Company uses the best
available information to prepare its cash flow and discount rate assumptions,
actual future cash flows or market conditions could differ significantly
resulting in future impairment charges related to recorded intangible balances.
While there are always changes in assumptions to reflect changing business and
market conditions, the Company's overall methodology and the population of
assumptions used have remained unchanged.

The Company's acquisitions have generally included a significant goodwill
component and the Company expects to continue to make acquisitions. At
December 31, 2022, goodwill and other indefinite-lived intangible assets totaled
$6,262.2 million or 50.4% of the Company's total assets. The Company completed
its required annual indefinite-lived intangibles impairment tests in the fourth
quarter of 2022 and determined that the carrying values of certain of the
Company's indefinite-lived intangibles were impaired as a result of higher
discount rates driven by higher interest rates. As a result, in the fourth
quarter of 2022, the Company recorded an immaterial non-cash impairment charge
related to certain of the Company's trade names. The Company completed its
annual qualitative goodwill impairment test in the fourth quarter of 2022 and
determined the carrying values of its goodwill intangibles were not impaired.
There can be no assurance that goodwill or indefinite-lived intangibles
impairment will not occur in the future.

•Pensions. The Company has U.S. and foreign defined benefit and defined
contribution pension plans. The most significant elements in determining the
Company's pension income or expense are the assumed pension liability discount
rate and the expected return on plan assets. The pension discount rate reflects
the current interest rate at which the pension liabilities could be settled at
the valuation date. At the end of each year, the Company determines the assumed
discount rate to be used to discount plan liabilities. In estimating this rate
for 2022, the Company considered rates of return on high-quality, fixed-income
investments that have maturities consistent with the anticipated funding
requirements of the plan. In estimating the U.S. and foreign discount rates, the
Company's actuaries developed a customized discount
                                       31

--------------------------------------------------------------------------------

Table of Contents



rate appropriate to the plans' projected benefit cash flow based on yields
derived from a database of long-term bonds at consistent maturity dates. The
Company determines the expected long-term rate of return based primarily on its
expectation of future returns for the pension plans' investments. Additionally,
the Company considers historical returns on comparable fixed-income and equity
investments and adjusts its estimate as deemed appropriate.

•Income Taxes. The process of providing for income taxes and determining the
related balance sheet accounts requires management to assess uncertainties, make
judgments regarding outcomes and utilize estimates. The Company conducts a broad
range of operations around the world and is therefore subject to complex tax
regulations in numerous international taxing jurisdictions, resulting at times
in tax audits, disputes and potential litigation, the outcome of which is
uncertain. Management must make judgments currently about such uncertainties and
determine estimates of the Company's tax assets and liabilities. To the extent
the final outcome differs, future adjustments to the Company's tax assets and
liabilities may be necessary.

The Company assesses the realizability of its deferred tax assets, taking into
consideration the Company's forecast of future taxable income, available net
operating loss carryforwards and available tax planning strategies that could be
implemented to realize the deferred tax assets. Based on this assessment,
management must evaluate the need for, and the amount of, valuation allowances
against the Company's deferred tax assets. To the extent facts and circumstances
change in the future, adjustments to the valuation allowances may be required.

The Company assesses the uncertainty in its tax positions, by applying a minimum
recognition threshold which a tax position is required to meet before a tax
benefit is recognized in the financial statements. Once the minimum threshold is
met, using a more likely than not standard, a series of probability estimates is
made for each item to properly measure and record a tax benefit. The tax benefit
recorded is generally equal to the highest probable outcome that is more than
50% likely to be realized after full disclosure and resolution of a tax
examination. The underlying probabilities are determined based on the best
available objective evidence such as recent tax audit outcomes, published
guidance, external expert opinion, or by analogy to the outcome of similar
issues in the past. There can be no assurance that these estimates will
ultimately be realized given continuous changes in tax policy, legislation and
audit practice. The Company recognizes interest and penalties accrued related to
uncertain tax positions in income tax expense.

Recent Accounting Pronouncements

See Note 2, Recent Accounting Pronouncements, to the Company's Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for information regarding recently issued accounting pronouncements.

Forward-Looking Information



Certain matters discussed in this Form 10-K are "forward-looking statements" as
defined in the Private Securities Litigation Reform Act of 1995 ("PSLRA"), which
involve risk and uncertainties that exist in the Company's operations and
business environment and can be affected by inaccurate assumptions, or by known
or unknown risks and uncertainties. Many such factors will be important in
determining the Company's actual future results. The Company wishes to take
advantage of the "safe harbor" provisions of the PSLRA by cautioning readers
that numerous important factors in some cases have caused, and in the future
could cause, the Company's actual results to differ materially from those
expressed in any forward-looking statements made by, or on behalf of, the
Company. Some, but not all, of the factors or uncertainties that could cause
actual results to differ from present expectations are set forth above and under
Item 1A. Risk Factors. The Company undertakes no obligation to publicly update
any forward-looking statements, whether as a result of new information,
subsequent events or otherwise, unless required by the securities laws to do so.
                                       32

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses